I am a
Home I AM A Search Login

Papers of the Week

2021 Apr 28

Int J Surg

Effects of parecoxib after pancreaticoduodenectomy: A single center randomized controlled trial.


Liu G, Ma Y, Chen Y, Zhuang Y, Yang Y, Tian X
Int J Surg. 2021 Apr 28:105962.
PMID: 33932589.


Parecoxib, a selective cyclooxygenase-2 inhibitor, is a potential alternative analgesic to reduce opioid consumption after Pancreaticoduodenectomy (PD). Further, the safety and efficacy of long-term use of parecoxib for patients after PD remain a major concern.